Oarsman Capital, Inc.
Source: SEC Form 13F · as of Mar 2026Oarsman Capital, Inc. holds 14 biotech & pharma companies tracked by BioSniper, totaling $23.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$23.8M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 18,908 | $4.6M |
| ABBVAbbVie Inc. | 19,598 | $4.3M |
| AZNASTRAZENECA PLC | 16,553 | $3.3M |
| BMYBRISTOL MYERS SQUIBB CO | 41,654 | $2.5M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 4,983 | $2.2M |
| LLYELI LILLY & Co | 2,061 | $1.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,452 | $1.2M |
| AMGNAMGEN INC | 2,339 | $823K |
| PFEPFIZER INC | 24,020 | $674K |
| ABTABBOTT LABORATORIES | 6,530 | $670K |
| NVSNovartis AG | 4,320 | $660K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 6,309 | $348K |
| IDXXIDEXX LABORATORIES INC /DE | 593 | $333K |
| PMPhilip Morris International Inc | 1,744 | $288K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.